Is Oxford Nanopore worth $2B?; Software outfit Appistry to collaborate with genomics center in Singapore;

> A $400 million OTC brand has begun using Semantelli's AETracker software for tracking adverse events and other negative feedback from patients on Facebook. Release

> The New York Genome Center has named Dr. Robert Darnell of Rockefeller University as its scientific director. Report

> Comprehensive Clinical Development, a contract research organization, has inked a deal to standardize its studies on Datatrak International's eclinical software. Item

> Privately held Oxford Nanopore has fetched a valuation of $2 billion. Is it worth that much? Article

> Appistry, a provider of high-performance computing, will team up with the Genomics Institute of Singapore to more effectively analyze next-generation sequencing data. Report

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.